Circio Holding ASA

FRA:TA50 (Norway)  
€ 0.18 (-3.24%) Apr 24
At Loss
Market Cap:
€ 1.97M ($ 2.11M)
Enterprise V:
€ 7.69M ($ 8.24M)
Volume:
-
Avg Vol (2M):
18.00
Also Trade In:

Business Description

Description
Circio Holding ASA is a clinical-stage company. It is focused on developing and commercializing immuno-oncology therapies to target treatment-resistant solid tumors. Its product candidate, ONCOS-102, is a genetically modified oncolytic adenovirus, which has been engineered to infect cancer cells and activate the immune system to fight cancer. It includes the development and implementation with the purpose of developing targeted immunotherapy treatments for cancer patients.
Name Current Vs Industry Vs History
Cash-To-Debt 0.32
Equity-to-Asset -1.44
Debt-to-Equity -1.37
Debt-to-EBITDA -1.01
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -36.13
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 24.89
9-Day RSI 27.07
14-Day RSI 30.49
6-1 Month Momentum % -6.33
12-1 Month Momentum % -65.62

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.74
Quick Ratio 0.74
Cash Ratio 0.53
Days Sales Outstanding 417.66

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -34.5
Shareholder Yield % -61
Name Current Vs Industry Vs History
Operating Margin % -4934.94
Net Margin % -4328.12
FCF Margin % -1122.8
ROE % -262.14
ROA % -146.49
ROIC % -182.66
ROC (Joel Greenblatt) % -12248.42
ROCE % -196.24

GF Value Rank

Name Current Vs Industry Vs History
Price-to-Owner-Earnings 4.03
PS Ratio 1.82
EV-to-EBIT -0.18
EV-to-EBITDA -0.93
EV-to-Revenue 9.05
EV-to-FCF -0.83
Earnings Yield (Greenblatt) % -554.19
FCF Yield % -468.88

Financials (Next Earnings Date:2024-08-24 Est.)

FRA:TA50's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Circio Holding ASA Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 0.956
EPS (TTM) (€) -6.614
Beta 2.12
Volatility % 61.57
14-Day RSI 30.49
14-Day ATR (€) 0.041381
20-Day SMA (€) 0.334925
12-1 Month Momentum % -65.62
52-Week Range (€) 0.143 - 1.95
Shares Outstanding (Mil) 8.11

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Circio Holding ASA Filings

Filing Date Document Date Form
No Filing Data

Circio Holding ASA Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Circio Holding ASA Frequently Asked Questions

What is Circio Holding ASA(FRA:TA50)'s stock price today?
The current price of FRA:TA50 is €0.18. The 52 week high of FRA:TA50 is €1.95 and 52 week low is €0.14.
When is next earnings date of Circio Holding ASA(FRA:TA50)?
The next earnings date of Circio Holding ASA(FRA:TA50) is 2024-08-24 Est..
Does Circio Holding ASA(FRA:TA50) pay dividends? If so, how much?
Circio Holding ASA(FRA:TA50) does not pay dividend.

Press Release

Subject Date
No Press Release